- Home
- LVTX vs MODD Comparison
LVTX vs MODD Comparison
Compare LVTX & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- MODD
- Stock Information
- Founded
- LVTX 2016
- MODD 1998
- Country
- LVTX Netherlands
- MODD United States
- Employees
- LVTX N/A
- MODD N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- MODD Industrial Specialties
- Sector
- LVTX Health Care
- MODD Health Care
- Exchange
- LVTX Nasdaq
- MODD Nasdaq
- Market Cap
- LVTX 34.2M
- MODD 35.5M
- IPO Year
- LVTX 2021
- MODD N/A
- Fundamental
- Price
- LVTX $1.25
- MODD $1.13
- Analyst Decision
- LVTX Hold
- MODD
- Analyst Count
- LVTX 3
- MODD 0
- Target Price
- LVTX $3.17
- MODD N/A
- AVG Volume (30 Days)
- LVTX 72.6K
- MODD 126.9K
- Earning Date
- LVTX 03-28-2025
- MODD 02-13-2025
- Dividend Yield
- LVTX N/A
- MODD N/A
- EPS Growth
- LVTX N/A
- MODD N/A
- EPS
- LVTX N/A
- MODD N/A
- Revenue
- LVTX $11,982,000.00
- MODD N/A
- Revenue This Year
- LVTX $16.68
- MODD N/A
- Revenue Next Year
- LVTX N/A
- MODD N/A
- P/E Ratio
- LVTX N/A
- MODD N/A
- Revenue Growth
- LVTX 77.01
- MODD N/A
- 52 Week Low
- LVTX $0.85
- MODD $0.68
- 52 Week High
- LVTX $3.57
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- LVTX 49.47
- MODD 59.84
- Support Level
- LVTX $1.20
- MODD $1.05
- Resistance Level
- LVTX $1.36
- MODD $1.29
- Average True Range (ATR)
- LVTX 0.08
- MODD 0.12
- MACD
- LVTX -0.02
- MODD 0.03
- Stochastic Oscillator
- LVTX 29.41
- MODD 67.84
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.